ISO-20399-2 Biotechnology - Ancillary materials present during the production of cellular therapeutic products - Part 2: Best practice guidance for ancillary material suppliers

ISO-20399-2 - 1ST EDITION - CURRENT


Document Center Inc. is an authorized dealer of ISO standards.
The following bibliographic material is provided to assist you with your purchasing decision:


This document provides guidance for ancillary material (AM) suppliers to maintain a high level of lot-to-lot consistency in the aspects of identity, purity, stability, biosafety, performance, as well as the accompanying documentation.

This document is applicable to cellular therapeutic products, including gene therapy products whereby cells form part of the final product. It does not apply to products without cells.

The AMs described in this document include those of biological origin [e.g. sera, media (including media additives), growth factors, and monoclonal antibodies] and chemical origin. This document does not address dimethyl sulfoxide (DMSO) for cryopreservation, beads, scaffolds, feeder cells, apparatus and instruments, or additives used post bioprocessing.

This document does not cover the selection, assessment or control of starting materials and excipients.

NOTE International, regional or national regulations or requirements can also apply to specific topics covered in this document.

ORDER

Price:

$78.57        


Want this as a site license?

To find similar documents by classification:

07.080 (Biology. Botany. Zoology Including biotechnology)

This document comes with our free Notification Service, good for the life of the document.

This document is available in either Paper or PDF format.

Document Number

ISO/TS 20399-2:2018

Revision Level

1ST EDITION

Status

Current

Publication Date

Nov. 1, 2018

Committee Number

ISO/TC 276